Article citationsMore>>

Wilhelm, S., Carter, C., Lynch, M., Lowinger, T., Dumas, J., Smith, R.A., et al. (2006) Discovery and Development of Sorafenib: A Multikinase Inhibitor for Treating Cancer. Nature Reviews Drug Discovery, 5, 835-844.
https://doi.org/10.1038/nrd2130

has been cited by the following article:

• TITLE: Morphological Structure of the Thyroid Gland of White Rats in Chemotherapy of Breast Cancer

  AUTHORS: Khalikova Feruza Sharofovna, Sultinova Lola Djaxonqulovna, Mamedov Umid Sunnatovich

  KEYWORDS: Cancer, Chemotherapy, Follicle, Theriocyte, Hormone, B-Cell, C-Cell, Thyroid Substance, Epithelium, Stroma, Parenchyma

  JOURNAL NAME: Advances in Breast Cancer Research, Vol.15 No.3, July 16, 2026

  ABSTRACT: Paclitaxel used in chemotherapy of breast cancer is an inhibitor of mitosis and is obtained from plants. They block cell division, disrupt the function of microtubules and some enzyme proteins. They change the metabolism of amino acids and some other substances, such as nucleic acids, fat synthesis, and also affect cellular respiration. When we modeled breast cancer in 6-month-old rats and carried out chemotherapy using paclitaxel, we encountered various pathomorphological changes.